Editorial: Multiple Myeloma Immunotherapies
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
2017
|
| In: |
Current cancer drug targets
Year: 2017, Volume: 17, Issue: 9, Pages: 768 |
| ISSN: | 1873-5576 |
| DOI: | 10.2174/156800961709171005160041 |
| Online Access: | Verlag, Volltext: http://doi.org/10.2174/156800961709171005160041 Verlag, Volltext: http://www.eurekaselect.com/156232/article 
|
| Author Notes: | Klaus Podar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1574983997 | ||
| 003 | DE-627 | ||
| 005 | 20230427042858.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180511s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/156800961709171005160041 |2 doi | |
| 035 | |a (DE-627)1574983997 | ||
| 035 | |a (DE-576)504983997 | ||
| 035 | |a (DE-599)BSZ504983997 | ||
| 035 | |a (OCoLC)1341009474 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Podar, Klaus |e VerfasserIn |0 (DE-588)1058672169 |0 (DE-627)797396594 |0 (DE-576)414826795 |4 aut | |
| 245 | 1 | 0 | |a Editorial |b Multiple Myeloma Immunotherapies |c Klaus Podar |
| 264 | 1 | |c 2017 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.05.2018 | ||
| 500 | |a DOI ist falsch | ||
| 773 | 0 | 8 | |i Enthalten in |t Current cancer drug targets |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 9, Seite 768 |h Online-Ressource |w (DE-627)362755582 |w (DE-600)2099324-9 |w (DE-576)273874209 |x 1873-5576 |7 nnas |a Editorial Multiple Myeloma Immunotherapies |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:9 |g pages:768 |g extent:1 |a Editorial Multiple Myeloma Immunotherapies |
| 856 | 4 | 0 | |u http://doi.org/10.2174/156800961709171005160041 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.eurekaselect.com/156232/article |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180511 | ||
| 993 | |a Editorial | ||
| 994 | |a 2017 | ||
| 998 | |g 1058672169 |a Podar, Klaus |m 1058672169:Podar, Klaus |d 910000 |d 910100 |e 910000PP1058672169 |e 910100PP1058672169 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1574983997 |e 3009146469 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"Multiple Myeloma Immunotherapies","title":"Editorial","title_sort":"Editorial"}],"person":[{"display":"Podar, Klaus","roleDisplay":"VerfasserIn","role":"aut","family":"Podar","given":"Klaus"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 11.05.2018","DOI ist falsch"],"language":["eng"],"recId":"1574983997","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"id":{"eki":["1574983997"],"doi":["10.2174/156800961709171005160041"]},"name":{"displayForm":["Klaus Podar"]},"physDesc":[{"extent":"1 S."}],"relHost":[{"id":{"issn":["1873-5576"],"zdb":["2099324-9"],"eki":["362755582"]},"origin":[{"publisherPlace":"Hilversum [u.a.]","dateIssuedKey":"2001","publisher":"Bentham Science Publ.","dateIssuedDisp":"2001-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Current cancer drug targets","title_sort":"Current cancer drug targets"}],"part":{"issue":"9","pages":"768","year":"2017","extent":"1","volume":"17","text":"17(2017), 9, Seite 768"},"pubHistory":["1.2001 -"],"language":["eng"],"recId":"362755582","note":["Gesehen am 09.04.24"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Editorial Multiple Myeloma ImmunotherapiesCurrent cancer drug targets"}]} | ||
| SRT | |a PODARKLAUSEDITORIAL2017 | ||